Page 6 - 台灣肝癌醫學冬季會手冊-1222-V3_Neat
P. 6
W elcome Message
Dear colleagues, distinguished guests, ladies, and gentlemen:
On behalf of the Taiwan Liver Cancer Association
(TLCA), it is my great honor and pleasure to welcome you to the
2020 Educational Conference of TLCA held at Mackay
memorial hospital on 26-27 Dec. 2020 in
Tai tung. The theme of this meeting is "Post-ESMO Update
From clinical trial to real-world data."
Over the past ten years, the treatment of hepatoma has an
evolutional change. This time, we invite experts to update the
knowledge of diagnosis, surgical treatment, current trends in the
systemic treatment of hepatoma, and the risk of hepatoma after
treatment of hepatitis B and C. I greatly appreciate all our
speakers and moderators for your contributions to the meeting. I
cordially invite our members to join this important event. I hope
everyone can enjoy and have fruitful discussions during the
meeting.
Lastly, I wish you a happy stay in Taitung.
Best regards, Ming-Jong Bair
